Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but does not diminish Humoral Immunity and Efficacy of a DNA/MVA Vaccine

類似資料

• OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
  著者:: Kannanganat, S, 等
  出版事項: (2009)
• High doses of granulocyte-macrophage colony stimulating factor inhibit antibody responses in rectal secretions and diminish MVA/SIV vaccine protection in TRIM5α restrictive macaques
  著者:: Kannanganat, Sunil, 等
  出版事項: (2016)
• DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  著者:: Nigam, Pragati, 等
  出版事項: (2007)
• GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
  著者:: Robinson, H, 等
  出版事項: (2012)
• Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade
  著者:: Velu, Vijayakumar, 等
  出版事項: (2008)